Cargando…
Survivin as a Preferential Target for Cancer Therapy
Cancer is typically a consequence of imbalance between cell death and proliferation in a way favorable to cell proliferation and survival. Most conventional cancer therapies are based on targeting rapidly growing cancerous cells to block growth or enhance cell death, thereby, restoring the balance b...
Autores principales: | Mobahat, Mahsa, Narendran, Aru, Riabowol, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958864/ https://www.ncbi.nlm.nih.gov/pubmed/24531137 http://dx.doi.org/10.3390/ijms15022494 |
Ejemplares similares
-
Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition
por: Jayanthan, Aarthi, et al.
Publicado: (2011) -
ING3 promotes prostate cancer growth by activating the androgen receptor
por: Nabbi, Arash, et al.
Publicado: (2017) -
Survivin: a unique target for tumor therapy
por: Garg, Himani, et al.
Publicado: (2016) -
Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
por: Reynolds, Carson R., et al.
Publicado: (2022) -
The Developmental Origins of Cancer: A Review of the Genes Expressed in Embryonic Cells with Implications for Tumorigenesis
por: Balachandran, Savitha, et al.
Publicado: (2023)